Is adrenaline (epinephrine) safe to use during pregnancy, and what are the recommended doses for cardiac arrest, anaphylaxis, and severe asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adrenaline in Pregnancy: Safety and Dosing

Adrenaline (epinephrine) is safe and essential to use during pregnancy for life-threatening emergencies including anaphylaxis and cardiac arrest, with no absolute contraindications—maternal survival is the priority for both mother and fetus. 1, 2

Safety Profile in Pregnancy

The FDA classifies epinephrine as Pregnancy Category C, meaning animal studies show potential teratogenic effects (gastroschisis, embryonic lethality) at doses 2-15 times the maximum recommended human dose, but no adequate human studies exist 1, 2. However, this classification becomes irrelevant in emergency situations where maternal life is threatened.

Critical principle: The best hope for fetal survival is maternal survival 3. Do not withhold epinephrine due to pregnancy concerns when treating life-threatening conditions 4, 2.

Physiological Considerations

  • Uterine vasoconstriction risk: Epinephrine may decrease uterine blood flow and cause fetal anoxia 1, 2
  • Labor effects: May inhibit uterine contractions and delay second stage of labor; avoid during active second stage unless treating anaphylaxis 2
  • Hemorrhage risk: Can cause prolonged uterine atony with bleeding if used to reduce contractions 2

Despite these theoretical concerns, immediate epinephrine administration for anaphylaxis or cardiac arrest takes absolute priority 5, 6.

Recommended Doses by Indication

Anaphylaxis (First-Line Treatment)

Intramuscular (IM) route is preferred:

  • Adult dose: 0.5 mg of 1:1000 (1 mg/mL) solution IM into mid-outer thigh 7, 8, 5
  • Weight-based: 0.01 mg/kg (maximum 0.5 mg adults, 0.3 mg children) 9, 8
  • Repeat: Every 5-15 minutes as needed 7, 8
  • Auto-injector doses: 0.3 mg (adult), 0.15 mg (pediatric), 0.1 mg (infant) 8

The dosing is identical in pregnant and non-pregnant patients 5.

Intravenous (IV) route for refractory anaphylaxis:

  • Use only when IM doses fail and patient has profound hypotension or cardiac arrest 9, 3
  • IV bolus: 0.05-0.1 mg (50-100 mcg) of 1:10,000 solution, given slowly 3, 7
  • IV infusion: 5-15 mcg/min, titrated to blood pressure and clinical response 3, 7, 8
    • Prepare: 1 mg in 250 mL D5W = 4 mcg/mL concentration 9
    • Alternative: 1 mg in 100 mL saline, infuse at 30-100 mL/hr 9
  • Continuous hemodynamic monitoring is mandatory 9, 3

A case report demonstrates successful use of continuous IV epinephrine infusion during labor for anaphylactic shock without further fetal compromise 10.

Cardiac Arrest

Standard ACLS dosing applies in pregnancy:

  • IV/IO dose: 1 mg of 1:10,000 solution every 3-5 minutes 4, 11
  • High-dose for refractory arrest: May escalate to 3-5 mg, then 4-10 mg/min infusion 9
  • Pediatric: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution, max 0.3 mg initially) 9

Pregnancy-specific modifications during resuscitation:

  • Position patient in full left-lateral tilt to relieve inferior vena cava compression 3
  • Establish IV access above the diaphragm 3
  • Administer 100% oxygen 3
  • Consider perimortem cesarean delivery if no ROSC within 4 minutes 4

Severe Asthma

While the provided evidence focuses primarily on anaphylaxis and cardiac arrest, one study suggests:

  • Subcutaneous: 0.5 mg provides optimal bronchodilation for acute asthma 12
  • However, nebulized albuterol (2.5-5 mg) is preferred for bronchospasm resistant to epinephrine 9

Clinical Algorithm for Pregnant Patients

Step 1: Recognize Emergency

  • Anaphylaxis: Hypotension, airway swelling, difficulty breathing, urticaria
  • Cardiac arrest: Loss of pulse, unresponsiveness

Step 2: Immediate Epinephrine

  • Anaphylaxis: 0.5 mg IM in anterolateral thigh
  • Cardiac arrest: 1 mg IV/IO every 3-5 minutes
  • Do not delay for pregnancy concerns

Step 3: Supportive Measures

  • Position in left-lateral tilt (if not in cardiac arrest)
  • Establish IV access above diaphragm
  • Aggressive fluid resuscitation: 1-2 L normal saline rapidly 9
  • Oxygen 6-8 L/min or 100% 9, 3

Step 4: Escalate if Refractory

  • Anaphylaxis: Switch to IV epinephrine infusion 5-15 mcg/min 3, 7
  • Cardiac arrest: Continue ACLS, consider perimortem cesarean delivery at 4 minutes 4

Step 5: Adjunctive Therapy

  • Diphenhydramine 25-50 mg IV/IM 9
  • Ranitidine 50 mg IV (1 mg/kg in children) 9
  • Corticosteroids for prolonged anaphylaxis 9
  • Glucagon 1-5 mg if patient on beta-blockers 9

Critical Pitfalls to Avoid

  1. Dosing confusion: The cardiac arrest dose (1 mg IV) is 10-20 times higher than the anaphylaxis IV dose (0.05-0.1 mg). Fatal overdoses occur when cardiac arrest doses are given for anaphylaxis 13. Use prefilled, clearly labeled syringes to prevent errors.

  2. Route errors: Never give IM doses intravenously—this causes severe hypertension and arrhythmias 13.

  3. Delayed administration: Epinephrine underuse and delay are the leading causes of anaphylaxis deaths 8, 14. There is no absolute contraindication to epinephrine in anaphylaxis, including pregnancy 9.

  4. Wrong injection site: IM epinephrine must go in the anterolateral thigh (vastus lateralis), not the deltoid—thigh injection produces higher plasma levels faster 9, 8.

  5. Withholding due to pregnancy: Some older guidelines suggested ephedrine for pregnant patients, but ephedrine is less potent and lacks anti-inflammatory/bronchodilating effects 6. Adrenaline remains first-line.

  6. Inadequate monitoring: IV epinephrine requires continuous hemodynamic monitoring due to arrhythmia risk 9, 3. Monitor blood pressure every minute and use ECG monitoring.

Evidence Quality and Nuances

The strongest evidence comes from 2020 AHA Guidelines 7 and 2015 AHA Cardiac Arrest in Pregnancy Statement 4, both Class I recommendations. The 2020 Anaphylaxis Practice Parameter 8 provides the most comprehensive dosing guidance.

Important limitation: No randomized trials exist specifically evaluating epinephrine in pregnant patients—recommendations extrapolate from general population data and case reports 5, 10. However, the physiological rationale and case evidence strongly support standard dosing.

The FDA drug labels 1, 2 acknowledge teratogenic risk in animals but explicitly state epinephrine should be used "if the potential benefit justifies the potential risk" and that "life-sustaining therapy should not be withheld for a pregnant woman" 2.

Human case reports demonstrate successful outcomes with both IM and IV epinephrine during pregnancy, including during active labor 10.

References

Research

Acute management of anaphylaxis in pregnancy.

Australian journal of general practice, 2022

Guideline

the diagnosis and management of anaphylaxis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2005

Research

Optimal dosing of epinephrine in acute asthma.

American journal of hospital pharmacy, 1980

Related Questions

What are the indications for epinephrine and the recommended doses for anaphylaxis, cardiac arrest, severe bronchospasm, refractory hypotension, and as a vasoconstrictor adjunct to local anesthesia?
What is the immediate management of anaphylaxis?
What medications are recommended for treating an acute allergic reaction?
What is the appropriate acute management and follow‑up for a 22‑year‑old male who, 2 hours after an unknown allergen exposure, presents with a 1 mm wheal on the right upper inner lip, mild associated swelling and throbbing, mild tongue and throat itching, stable vital signs, and who declines immediate epinephrine?
What are the recommended dilution concentrations and preparation methods for adrenaline (epinephrine) for intravenous infusion in cardiac arrest, subcutaneous or intramuscular anaphylaxis, and local infiltration anesthesia?
What does an NT‑proBNP level of 5,299 pg/mL indicate and what immediate management steps are recommended?
What is the recommended protocol for switching a patient from sertraline 200 mg daily to clomipramine, including tapering schedule, initial dosing, and necessary monitoring?
What is the appropriate next dose of clonazepam for a patient currently taking 1 mg orally every 8 hours for anxiety?
How should a 72-year-old man with a PSA of 19 ng/mL be evaluated and managed?
What is the most likely diagnosis for a patient with persistent tachycardia, palpitations, diaphoresis, dyspnea, insomnia, and light‑headedness who has no known cardiac disease?
Should aspirin be held before pleural catheter placement?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.